CRKL is a critical target of Hh-GLI2 pathway in lung adenocarcinoma - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/34076957/

Lung adenocarcinoma (LUAD) is one of the important components of non-small-cell lung cancer (NSCLC) and leads to many deaths every year. During the initiation and progression of the LUAD, the Hh-GLI2 pathway plays critical roles. Several components of this pathway have been shown to be amplified or ...